Page 6 | Certara

On-Demand Webinar

Simcyp® Simulator Version 25: Streamline Drug Development with Regulatory-Compliant PBPK

JTVCdGVhbV9tZW1iZXJzJTVESenior Principal ScientistAssociate Principal ScientistPrincipal ScientistSenior Research ScientistDiscover real-world success stories where sponsors leveraged Simcyp…

CertaraFebruary 12, 2026

Guide

EMA Policy 0070 Submission Readiness Checklist

Use this EMA Policy 0070 Submission Checklist to prepare compliant clinical data packages, manage anonymization…

CertaraFebruary 12, 2026

On-Demand Webinar

The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)

Watch to see how Phoenix TFL Studio and AI PK Reports automate the final stages…

CertaraFebruary 12, 2026

Live Events

Certara IQ^™ Global Roadshow

Certara IQ™ is going on the road. From APAC to Europe to North America, our…

CertaraFebruary 12, 2026

Live Events

Certara IQ™ Workshop

CertaraFebruary 11, 2026

Publication

Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-Analysis

Anti-PD-1 and anti-PD-L1 antibodies have transformed cancer immunotherapy, yet clinical meta-analyses suggest differences in efficacy…

CertaraFebruary 11, 2026

Blog

Pediatric Drug Development: From “Wild West” to Model-Informed Confidence

Model-informed drug development and precision dosing are transforming pediatric programs, from regulatory planning to Bayesian…

CertaraFebruary 11, 2026

Blog

QSP in Inflammatory Bowel Disease (IBD): From Biomarkers to Clinical Endpoints, with Virtual Patients

Certara supports IBD drug development with a QSP model that predicts Mayo score and CDAI…

CertaraFebruary 10, 2026

Announcement

Certara Introduces CRF Creator Module in Pinnacle 21® Enterprise for Faster Clinical Study Start-Up in Drug Development

Discover Pinnacle 21® Enterprise Plus' new CRF Creator module, designed to speed clinical study start-up…

CertaraFebruary 6, 2026

Press Coverage

Why Many Global Drugs Never Reach Japan

Despite faster reviews, many global drugs never reach Japan. Learn how early development decisions, trial…

CertaraFebruary 5, 2026

Simcyp® Simulator Version 25: Streamline Drug Development with Regulatory-Compliant PBPK

EMA Policy 0070 Submission Readiness Checklist

The “Easy Button” for PK/PD TFLs and Reports (TFL Studio & AI PK Reports)

Certara IQ^™ Global Roadshow

Certara IQ™ Workshop

Anti-PD-(L)1 Antibodies: Insights From QSP-Based Meta-Analysis

Pediatric Drug Development: From “Wild West” to Model-Informed Confidence

QSP in Inflammatory Bowel Disease (IBD): From Biomarkers to Clinical Endpoints, with Virtual Patients

Certara Introduces CRF Creator Module in Pinnacle 21® Enterprise for Faster Clinical Study Start-Up in Drug Development

Why Many Global Drugs Never Reach Japan

Newsletter sign up

Quick links

Solutions

Contact